Belcheva, V., MU-Varna, Bulgaria

• Vol 7, No 1 (2021) - Original Article
  Analysis of the cost-effectiveness of three-component therapies with daratumumab for the treatment of patients with recurrent refractory multiple myeloma
  Abstract  PDF